Illumina, Inc. (ILMN)
NASDAQ: ILMN · Real-Time Price · USD
131.45
+1.64 (1.26%)
At close: Nov 28, 2025, 1:00 PM EST
131.47
+0.02 (0.02%)
After-hours: Nov 28, 2025, 4:58 PM EST
Illumina Employees
Illumina had 10,370 employees as of December 31, 2024. The number of employees decreased by 2,020 or -16.30% compared to the previous year.
Employees
10,370
Change (1Y)
-2,020
Growth (1Y)
-16.30%
Revenue / Employee
$413,500
Profits / Employee
$67,792
Market Cap
20.09B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10,370 | -2,020 | -16.30% |
| Dec 31, 2023 | 12,390 | -970 | -7.26% |
| Dec 31, 2022 | 13,360 | 1,610 | 13.70% |
| Dec 31, 2021 | 11,750 | 2,400 | 25.67% |
| Dec 31, 2020 | 9,350 | 1,650 | 21.43% |
| Dec 29, 2019 | 7,700 | 400 | 5.48% |
| Dec 30, 2018 | 7,300 | 1,100 | 17.74% |
| Dec 31, 2017 | 6,200 | 700 | 12.73% |
| Dec 31, 2016 | 5,500 | 900 | 19.57% |
| Dec 31, 2015 | 4,600 | 900 | 24.32% |
| Dec 28, 2014 | 3,700 | 700 | 23.33% |
| Dec 29, 2013 | 3,000 | 800 | 36.36% |
| Dec 31, 2012 | 2,200 | -200 | -8.33% |
| Dec 30, 2012 | 2,400 | 300 | 14.29% |
| Dec 31, 2011 | 2,100 | 319 | 17.91% |
| Dec 31, 2010 | 1,781 | 245 | 15.95% |
| Dec 28, 2008 | 1,536 | 495 | 47.55% |
| Dec 30, 2007 | 1,041 | 445 | 74.66% |
| Dec 31, 2006 | 596 | 221 | 58.93% |
| Dec 31, 2005 | 375 | 97 | 34.89% |
| Dec 31, 2004 | 278 | 42 | 17.80% |
| Dec 28, 2003 | 236 | 3 | 1.29% |
| Dec 29, 2002 | 233 | 54 | 30.17% |
| Dec 30, 2001 | 179 | 74 | 70.48% |
| Dec 31, 2000 | 105 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ILMN News
- 10 days ago - Illumina, Inc. (ILMN) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript - Seeking Alpha
- 17 days ago - Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study - PRNewsWire
- 17 days ago - Illumina To Webcast Upcoming Investor Conference - PRNewsWire
- 19 days ago - Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks - PRNewsWire
- 23 days ago - Illumina Responds to Positive Updates from Chinese Ministry of Commerce - PRNewsWire
- 4 weeks ago - DNA Sequencing Firm Illumina Sees Strong Clinical Market Momentum, Stock Soars - Benzinga
- 4 weeks ago - Illumina, Inc. (ILMN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025 - PRNewsWire